Seeking Alpha

Salix Pharmaceuticals (SLXP -5%) lags the market today after Stifel Nicolaus cut the shares to...

Salix Pharmaceuticals (SLXP -5%) lags the market today after Stifel Nicolaus cut the shares to Hold on valuation, noting it doesn't expect any significant outperformance from the stock, given an already impressive move coming out of 2011.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs